Correlation Between Anixa Biosciences and Tonix Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Anixa Biosciences and Tonix Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anixa Biosciences and Tonix Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anixa Biosciences and Tonix Pharmaceuticals Holding, you can compare the effects of market volatilities on Anixa Biosciences and Tonix Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anixa Biosciences with a short position of Tonix Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anixa Biosciences and Tonix Pharmaceuticals.

Diversification Opportunities for Anixa Biosciences and Tonix Pharmaceuticals

0.03
  Correlation Coefficient

Significant diversification

The 3 months correlation between Anixa and Tonix is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Anixa Biosciences and Tonix Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tonix Pharmaceuticals and Anixa Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anixa Biosciences are associated (or correlated) with Tonix Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tonix Pharmaceuticals has no effect on the direction of Anixa Biosciences i.e., Anixa Biosciences and Tonix Pharmaceuticals go up and down completely randomly.

Pair Corralation between Anixa Biosciences and Tonix Pharmaceuticals

Given the investment horizon of 90 days Anixa Biosciences is expected to generate 0.49 times more return on investment than Tonix Pharmaceuticals. However, Anixa Biosciences is 2.05 times less risky than Tonix Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Tonix Pharmaceuticals Holding is currently generating about -0.19 per unit of risk. If you would invest  356.00  in Anixa Biosciences on September 1, 2024 and sell it today you would lose (26.00) from holding Anixa Biosciences or give up 7.3% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Anixa Biosciences  vs.  Tonix Pharmaceuticals Holding

 Performance 
       Timeline  
Anixa Biosciences 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Anixa Biosciences are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady forward indicators, Anixa Biosciences may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Tonix Pharmaceuticals 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Tonix Pharmaceuticals Holding are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Tonix Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Anixa Biosciences and Tonix Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Anixa Biosciences and Tonix Pharmaceuticals

The main advantage of trading using opposite Anixa Biosciences and Tonix Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anixa Biosciences position performs unexpectedly, Tonix Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tonix Pharmaceuticals will offset losses from the drop in Tonix Pharmaceuticals' long position.
The idea behind Anixa Biosciences and Tonix Pharmaceuticals Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios